Aptinyx Analyst Ratings
Aptinyx Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/16/2022 | — | Truist Securities | Downgrades | Buy → Hold | |
| 08/15/2022 | 425.9% | BMO Capital | $6 → $2 | Maintains | Outperform |
| 08/12/2022 | 425.9% | Piper Sandler | $6 → $2 | Downgrades | Overweight → Neutral |
| 08/05/2022 | 688.85% | SVB Leerink | $4 → $3 | Maintains | Outperform |
| 05/19/2022 | 1477.7% | Piper Sandler | $10 → $6 | Maintains | Overweight |
| 04/21/2022 | 951.8% | SVB Leerink | $10 → $4 | Maintains | Outperform |
| 04/14/2022 | 425.9% | HC Wainwright & Co. | $8 → $2 | Maintains | Buy |
| 04/08/2022 | 1214.75% | Truist Securities | $12 → $5 | Maintains | Buy |
| 04/08/2022 | 1214.75% | Cantor Fitzgerald | $11 → $5 | Maintains | Overweight |
| 12/20/2021 | 2529.5% | SVB Leerink | $12 → $10 | Maintains | Outperform |
| 01/29/2021 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 11/19/2020 | 2003.6% | HC Wainwright & Co. | $7 → $8 | Maintains | Buy |
| 11/13/2020 | 3055.4% | SVB Leerink | $14 → $12 | Maintains | Outperform |
| 10/28/2020 | 3055.4% | Cantor Fitzgerald | $9 → $12 | Maintains | Overweight |
| 10/27/2020 | 2529.5% | Piper Sandler | → $10 | Initiates Coverage On | → Overweight |
| 05/08/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
| 04/29/2020 | 1740.65% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 11/13/2019 | 3318.35% | BMO Capital | $15 → $13 | Maintains | Outperform |
| 09/12/2019 | 1740.65% | Wedbush | → $7 | Initiates Coverage On | → Outperform |
| 08/13/2019 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 03/22/2019 | 3055.4% | Cantor Fitzgerald | $18 → $12 | Maintains | Overweight |
| 01/17/2019 | 2003.6% | JP Morgan | $30 → $8 | Downgrades | Overweight → Neutral |
| 11/15/2018 | 10418.01% | Cantor Fitzgerald | → $40 | Initiates Coverage On | → Overweight |
| 07/16/2018 | 7788.51% | JP Morgan | → $30 | Initiates Coverage On | → Overweight |
| 07/16/2018 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 07/16/2018 | 8314.41% | BMO Capital | → $32 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 08/16/2022 | — | Truist证券 | 评级下调 | 购买→Hold | |
| 08/15/2022 | 425.9% | 蒙特利尔银行资本 | $6 → $2 | 维护 | 跑赢大盘 |
| 08/12/2022 | 425.9% | 派珀·桑德勒 | $6 → $2 | 评级下调 | 超重→中性 |
| 08/05/2022 | 688.85% | SVB Leerink | $4 → $3 | 维护 | 跑赢大盘 |
| 05/19/2022 | 1477.7% | 派珀·桑德勒 | $10 → $6 | 维护 | 超重 |
| 04/21/2022 | 951.8% | SVB Leerink | $10 → $4 | 维护 | 跑赢大盘 |
| 04/14/2022 | 425.9% | HC Wainwright公司 | $8 → $2 | 维护 | 买 |
| 04/08/2022 | 1214.75% | Truist证券 | $12 → $5 | 维护 | 买 |
| 04/08/2022 | 1214.75% | 康托·菲茨杰拉德 | $11 → $5 | 维护 | 超重 |
| 12/20/2021 | 2529.5% | SVB Leerink | $12 → $10 | 维护 | 跑赢大盘 |
| 01/29/2021 | — | 摩根大通 | 评级下调 | 中性→减持 | |
| 11/19/2020 | 2003.6% | HC Wainwright公司 | $7 → $8 | 维护 | 买 |
| 11/13/2020 | 3055.4% | SVB Leerink | $14 → $12 | 维护 | 跑赢大盘 |
| 10/28/2020 | 3055.4% | 康托·菲茨杰拉德 | $9 → $12 | 维护 | 超重 |
| 10/27/2020 | 2529.5% | 派珀·桑德勒 | → $10 | 开始承保 | →超重 |
| 05/08/2020 | — | 威廉·布莱尔 | 开始承保 | →跑赢大盘 | |
| 04/29/2020 | 1740.65% | HC Wainwright公司 | → $7 | 开始承保 | →购买 |
| 11/13/2019 | 3318.35% | 蒙特利尔银行资本 | $15 → $13 | 维护 | 跑赢大盘 |
| 09/12/2019 | 1740.65% | 韦德布什 | → $7 | 开始承保 | →跑赢大盘 |
| 08/13/2019 | — | 摩根大通 | 评级下调 | 中性→减持 | |
| 03/22/2019 | 3055.4% | 康托·菲茨杰拉德 | $18 → $12 | 维护 | 超重 |
| 01/17/2019 | 2003.6% | 摩根大通 | $30 → $8 | 评级下调 | 超重→中性 |
| 11/15/2018 | 10418.01% | 康托·菲茨杰拉德 | → $40 | 开始承保 | →超重 |
| 07/16/2018 | 7788.51% | 摩根大通 | → $30 | 开始承保 | →超重 |
| 07/16/2018 | — | 考恩公司 | 开始承保 | →跑赢大盘 | |
| 07/16/2018 | 8314.41% | 蒙特利尔银行资本 | → $32 | 开始承保 | →跑赢大盘 |
Aptinyx Questions & Answers
Aptinyx问答
The latest price target for Aptinyx (NASDAQ: APTX) was reported by BMO Capital on August 15, 2022. The analyst firm set a price target for $2.00 expecting APTX to rise to within 12 months (a possible 425.90% upside). 9 analyst firms have reported ratings in the last year.
蒙特利尔银行资本公司于2022年8月15日报道了Aptinyx(纳斯达克代码：APTX)的最新目标价。这家分析公司将目标价定为2美元，预计aptX将在12个月内上涨至(可能上涨425.90%)。去年有9家分析公司公布了评级。
The latest analyst rating for Aptinyx (NASDAQ: APTX) was provided by BMO Capital, and Aptinyx maintained their outperform rating.
蒙特利尔银行资本提供了对Aptinyx(纳斯达克代码：APTX)的最新分析师评级，Aptinyx维持了其表现优于大盘的评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aptinyx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aptinyx was filed on August 15, 2022 so you should expect the next rating to be made available sometime around August 15, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Aptinyx的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Aptinyx的上一次评级是在2022年8月15日提交的，所以你应该预计下一次评级将在2023年8月15日左右的某个时候公布。
While ratings are subjective and will change, the latest Aptinyx (APTX) rating was a maintained with a price target of $6.00 to $2.00. The current price Aptinyx (APTX) is trading at is $0.38, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Aptinyx(APTX)评级维持不变，目标价在6.00美元至2.00美元之间。Aptinyx目前的交易价格为0.38美元，超出了分析师的预测区间。